London (PRWEB) November 25, 2013
The Europe Medical Devices Reports provide the latest available data, expert analysis and our independent 5-year forecasts for key European markets. Each country report covers political risk, the business environment, and macro-economic and industry prospects set against assumptions for the global economy.
Key uses of Medical Devices Reports
Forecast the pace and stability of each European country's economic and industry growth
Identify and evaluate adverse political and economic trends in key markets, to facilitate risk mitigation strategies
Assess critical shortcomings of each European country's business environment that pose hidden barriers and costs to corporate profitability
Contextualise individual European country risks against their European regional peers using BMI's country-comparative risk ratings system
Target business opportunities in the key-growth industry sectors
Evaluate external threats to doing business in each European country, including currency volatility, the commodity price boom and protectionist policies
Complete analysis to keep you informed
Now you can easily evaluate key European markets with Europe Medical Devices Reports. Each report provides individual and highly-detailed analysis of the market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access.
32 separate reports
Highly detailed analysis providing comprehensive regularly updated reports for leading markets in the region:
All 32 Country Reports
Highlights from the Reports
The Czech Republic was one of the larger and richer former Soviet countries to join the EU in May 2004. Its regulation and trade rules are now generally aligned to EU standards. It is well-located in central Europe and has an estimated population of 10.6 million in 2013. Healthcare funding is largely public, and mainly through health insurance. Private spending only accounts for an estimated 17% of total health expenditure. Provision of care is also largely public; the Czech Republic has yet to develop a substantial private sector. Responsibility for hospitals was devolved to local governments in 2003. This has shifted the burden of hospital debt to local authorities. Some are planning privatisation, although this is politically controversial and likely to be stopped by the national government.
The Netherlands has a well developed, comparatively mature medical device market, which is valued at US $3.3 million in 2012, equal to US $198 per capita.
The economic downturn, which resulted in a 1.1% contraction in the economy in 2012, has further increased financial pressures on the health service, which ran up sizeable deficits in 2009 and 2010. The volume of routine elective surgery continues to increase albeit with strong downward pressure on costs. Independent treatment centres are continuing to increase their share of the market. A liberal-labour coalition between the People's Party of Freedom and Democracy (PVVD) and the Labour Party (PvdA) as replaced the right-wing minority coalition between the PVVD and the Christian Democratic Appeal (CDA), following elections in September 2012.
GDP is the fourth largest in the eurozone, standing at US $1,382.7 billion in 2012. GDP is forecast to contract by 2.1% in 2012, compared to growth of 0.8% in 2011. Economic recovery is struggling, due to the eurozone debt crisis and the country’s unaffordable borrowing costs. All components of GDP by expenditure are set to suffer given the pressures facing the housing, banking, fiscal and external sectors of the economy. The economy is expected to return to growth in 2014, with GDP forecast to reach US$1,540.2 billion by 2017, equal to US $31,953 per capita. The current economic crisis has had a direct effect on the health sector in terms of some quite severe spending cuts, as well as rising co-payments.
Read the full report:
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48